Celecoxib and Multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Multiple sclerosis is reported as a side effect among people who take Celecoxib (celecoxib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Simponi, and have Ankylosing spondylitis.
The phase IV clinical study analyzes which people have Multiple sclerosis when taking Celecoxib. It is created by eHealthMe based on reports of 37,974 people who have side effects when taking Celecoxib from the FDA, and is updated regularly.
What is Celecoxib?
Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,359 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
37,974 people reported to have side effects when taking Celecoxib.
Among them, 95 people (0.25%) have Multiple sclerosis.

Among these 95 people:
How long have people been on Celecoxib when they have Multiple sclerosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 61.9 %
- 2 - 5 years: 4.76 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Multiple sclerosis when taking Celecoxib? *
- female: 65.17 %
- male: 34.83 %
What is the age of people who have Multiple sclerosis when taking Celecoxib? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 17.95 %
- 30-39: 15.38 %
- 40-49: 6.41 %
- 50-59: 48.72 %
- 60+: 11.54 %
What are other drugs people take besides Celecoxib? *
- Simponi: 19 people, 20.00%
- Naproxen: 18 people, 18.95%
- Lyrica: 17 people, 17.89%
- Ocrevus: 17 people, 17.89%
- Baclofen: 15 people, 15.79%
- Gabapentin: 13 people, 13.68%
- Tecfidera: 13 people, 13.68%
- Inflectra: 13 people, 13.68%
- Pregabalin: 12 people, 12.63%
- Clonazepam: 11 people, 11.58%
What are other side effects people have besides Multiple sclerosis? *
- Back Pain: 39 people, 41.05%
- Urinary Tract Infection: 39 people, 41.05%
- Intervertebral Disc Protrusion (spinal disc protrusion): 27 people, 28.42%
- Weakness: 26 people, 27.37%
- Fatigue (feeling of tiredness): 25 people, 26.32%
- Memory Loss: 23 people, 24.21%
- Balance Disorder: 21 people, 22.11%
- Rashes (redness): 21 people, 22.11%
- Upper Respiratory Tract Infection: 21 people, 22.11%
- Depression: 20 people, 21.05%
What are the existing conditions these people have? *
- Ankylosing Spondylitis (type of arthritis affecting the spine): 23 people, 24.21%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 20 people, 21.05%
- Urinary Tract Infection: 11 people, 11.58%
- Muscle Spasms (muscle contraction): 11 people, 11.58%
- Thyroid Diseases: 7 people, 7.37%
- Indigestion: 6 people, 6.32%
- Nausea And Vomiting: 6 people, 6.32%
- Urinary Tract Infection Bacterial: 5 people, 5.26%
- Neuralgia (pain in one or more nerves): 5 people, 5.26%
- Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Celecoxib and have Multiple sclerosis?
- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Celecoxib:
- Celecoxib (38,217 reports)
Multiple sclerosis treatments and more:
- Multiple sclerosis (799,636 reports)
How severe was Multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of celecoxib:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Celecoxib:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,088 drugs)
Browse all the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,359 conditions)
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celecoxib) and Celecoxib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cefazolin Sodium and Betamethasone Sodium Phosphate - 16 seconds ago
- Could Zyban cause Type 2 Diabetes? - 21 seconds ago
- Could Zyban cause Diabetes Mellitus Non-Insulin-Dependent? - 22 seconds ago
- Could Cobamamide cause Central Nervous System Lesion? - a minute ago
- Could Morphine cause Sedation? - a minute ago
- Drug interactions of Lansoprazole and Ritonavir - a minute ago
- Drug interactions of Janumet and Spiriva Respimat - a minute ago
- Menopause and Diverticulitis - a minute ago
- Drug interactions of Famotidine and Sunitinib Malate - a minute ago
- Could Symbicort cause Squamous Cell Carcinoma Of Skin? - a minute ago